Celgene Long Term Debt 2006-2018 | CELG

Celgene long term debt from 2006 to 2018. Long term debt can be defined as the sum of all long term debt fields.
  • Celgene long term debt for the quarter ending December 31, 2018 was $19.769B, a 24.82% increase year-over-year.
  • Celgene long term debt for 2018 was $19.769B, a 24.82% increase from 2017.
  • Celgene long term debt for 2017 was $15.838B, a 14.86% increase from 2016.
  • Celgene long term debt for 2016 was $13.789B, a 2.63% decline from 2015.
Celgene Annual Long Term Debt
(Millions of US $)
2018 $19,769
2017 $15,838
2016 $13,789
2015 $14,161
2014 $6,266
2013 $4,197
2012 $2,771
2011 $1,276
2010 $1,248
2009 $0
2008 $0
2007 $0
2006 $400
2005 $400
Celgene Quarterly Long Term Debt
(Millions of US $)
Q4 2018 $19,769
Q3 2018 $19,742
Q2 2018 $19,754
Q1 2018 $20,271
Q4 2017 $15,838
Q3 2017 $12,874
Q2 2017 $13,783
Q1 2017 $13,784
Q4 2016 $13,789
Q3 2016 $13,803
Q2 2016 $14,312
Q1 2016 $14,268
Q4 2015 $14,161
Q3 2015 $14,298
Q2 2015 $6,256
Q1 2015 $6,303
Q4 2014 $6,266
Q3 2014 $6,737
Q2 2014 $6,743
Q1 2014 $4,224
Q4 2013 $4,197
Q3 2013 $4,228
Q2 2013 $2,730
Q1 2013 $2,764
Q4 2012 $2,771
Q3 2012 $2,769
Q2 2012 $1,272
Q1 2012 $1,274
Q4 2011 $1,276
Q3 2011 $1,277
Q2 2011 $1,260
Q1 2011 $1,247
Q4 2010 $1,248
Q3 2010 $0
Q2 2010 $0
Q1 2010 $0
Q4 2009 $0
Q3 2009 $0
Q2 2009 $0
Q1 2009 $0
Q4 2008 $0
Q3 2008 $0
Q2 2008 $0
Q1 2008 $0
Q4 2007 $0
Q3 2007 $0
Q2 2007 $0
Q1 2007 $400
Q4 2006 $400
Q3 2006 $400
Q2 2006 $400
Q1 2006 $400
Q4 2005 $400
Q3 2005 $400
Q2 2005 $400
Q1 2005 $400
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $65.623B $15.281B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.629B 12.24
Gilead Sciences (GILD) United States $78.878B 10.04
Illumina (ILMN) United States $46.877B 55.78
Biogen (BIIB) United States $45.009B 8.72
Vertex Pharmaceuticals (VRTX) United States $43.083B 57.71
Regeneron Pharmaceuticals (REGN) United States $36.501B 16.96
Alexion Pharmaceuticals (ALXN) United States $28.819B 17.86
Incyte (INCY) United States $15.783B 147.32
BioMarin Pharmaceutical (BMRN) United States $14.932B 0.00
Exact Sciences (EXAS) United States $11.403B 0.00
Seattle Genetics (SGEN) United States $11.067B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.133B 52.39
Alnylam Pharmaceuticals (ALNY) United States $8.840B 0.00
QIAGEN (QGEN) Netherlands $8.567B 28.35
Sarepta Therapeutics (SRPT) United States $8.112B 0.00
Moderna (MRNA) United States $7.774B 0.00
Bluebird Bio (BLUE) United States $7.447B 0.00
Bio-Techne Corp (TECH) United States $7.219B 48.64
BeiGene (BGNE) Cayman Islands $7.182B 0.00
Exelixis (EXEL) United States $6.211B 14.41
Amarin (AMRN) Ireland $5.861B 0.00
Galapagos (GLPG) Belgium $5.857B 0.00
Guardant Health (GH) United States $5.494B 0.00
Alkermes (ALKS) Ireland $5.282B 0.00
Array BioPharma (ARRY) United States $4.871B 0.00
Ascendis Pharma (ASND) Denmark $4.598B 0.00
Horizon Pharma Public (HZNP) Ireland $4.524B 13.40
Spark Therapeutics (ONCE) United States $4.199B 0.00
China Biologic Products (CBPO) China $3.863B 23.93
ARGENX SE-ADR (ARGX) Netherlands $3.814B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.416B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.352B 0.00
Blueprint Medicines (BPMC) United States $3.326B 0.00
Immunomedics (IMMU) United States $3.171B 0.00
Allogene Therapeutics (ALLO) United States $3.133B 0.00
Global Blood Therapeutics (GBT) United States $3.040B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.022B 0.00
Amicus Therapeutics (FOLD) United States $2.839B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.696B 0.00
Emergent Biosolutions (EBS) United States $2.684B 22.32
Intercept Pharmaceuticals (ICPT) United States $2.584B 0.00
Ligand Pharmaceuticals (LGND) United States $2.573B 19.21
Repligen (RGEN) United States $2.413B 73.97
Akcea Therapeutics (AKCA) United States $2.412B 0.00
Denali Therapeutics (DNLI) United States $2.371B 0.00
Insmed (INSM) United States $2.369B 0.00
Genomic Health (GHDX) United States $2.343B 59.89
Myriad Genetics (MYGN) United States $2.339B 23.82
Halozyme Therapeutics (HALO) United States $2.338B 0.00
Reata Pharmaceuticals (RETA) United States $2.314B 0.00
Mirati Therapeutics (MRTX) United States $2.233B 0.00
Arena Pharmaceuticals (ARNA) United States $2.200B 0.00
Acceleron Pharma (XLRN) United States $2.111B 0.00
Medicines (MDCO) United States $2.097B 0.00
UniQure (QURE) Netherlands $1.985B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.979B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.947B 0.00
AnaptysBio (ANAB) United States $1.945B 0.00
MyoKardia (MYOK) United States $1.939B 0.00
NeoGenomics (NEO) United States $1.889B 153.69
REGENXBIO (RGNX) United States $1.845B 19.16
Zai Lab Unsponsored ADR (ZLAB) China $1.712B 0.00
Audentes Therapeutics (BOLD) United States $1.687B 0.00
Allakos (ALLK) United States $1.621B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.510B 0.00
Alector (ALEC) United States $1.474B 0.00
Atara Biotherapeutics (ATRA) United States $1.463B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.423B 0.00
Lion Biotechnologies (IOVA) United States $1.365B 0.00
Innoviva (INVA) United States $1.358B 3.74
Myovant Sciences (MYOV) United Kingdom $1.355B 0.00
InflaRx (IFRX) Germany $1.331B 0.00
Cambrex (CBM) United States $1.329B 14.31
Puma Biotechnology (PBYI) United States $1.303B 0.00
Editas Medicine (EDIT) United States $1.292B 0.00
Rubius Therapeutics (RUBY) United States $1.274B 0.00
Aimmune Therapeutics (AIMT) United States $1.270B 0.00
Sangamo Therapeutics (SGMO) United States $1.204B 0.00
Apellis Pharmaceuticals (APLS) United States $1.202B 0.00
Epizyme (EPZM) United States $1.151B 0.00
Codexis (CDXS) United States $1.096B 0.00
Gossamer Bio (GOSS) United States $1.090B 0.00
Clovis Oncology (CLVS) United States $1.077B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.057B 0.00
Fate Therapeutics (FATE) United States $1.055B 0.00
NGM BIOPHARMACT (NGM) United States $1.017B 0.00
Coherus BioSciences (CHRS) United States $1.009B 0.00
Genfit SA (GNFT) France $0.950B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.945B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.924B 0.00
Eidos Therapeutics (EIDX) United States $0.905B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.898B 0.00
RA PHARMCTL INC (RARX) United States $0.897B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.887B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.884B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.884B 35.72
WAVE Life Sciences (WVE) Singapore $0.881B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.874B 0.00
Twist Bioscience (TWST) United States $0.850B 0.00
Cellectis (CLLS) France $0.847B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.825B 0.00
Retrophin (RTRX) United States $0.824B 0.00
ANI Pharmaceuticals (ANIP) United States $0.815B 14.93
Intellia Therapeutics (NTLA) United States $0.739B 0.00
Arvinas (ARVN) United States $0.736B 0.00
Vericel (VCEL) United States $0.734B 0.00
Athenex (ATNX) United States $0.733B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.717B 0.00
Principia Biopharma (PRNB) United States $0.715B 0.00
Cara Therapeutics (CARA) United States $0.700B 0.00
Intra-Cellular Therapies (ITCI) United States $0.699B 0.00
G1 THERAPEUTICS (GTHX) United States $0.689B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.678B 0.00
Precision BioSciences (DTIL) United States $0.659B 0.00
Viking Therapeutics (VKTX) United States $0.628B 0.00
ObsEva SA (OBSV) Switzerland $0.620B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.602B 0.00
MeiraGTx Holdings (MGTX) United States $0.598B 0.00
Revance Therapeutics (RVNC) United States $0.591B 0.00
Stemline Therapeutics (STML) United States $0.580B 0.00
Heska (HSKA) United States $0.578B 51.83
Kura Oncology (KURA) United States $0.564B 0.00
Zealand Pharma (ZEAL) Denmark $0.563B 6.27
Synthorx (THOR) United States $0.558B 0.00
Zymeworks (ZYME) Canada $0.529B 0.00
Acorda Therapeutics (ACOR) United States $0.520B 6.74
DBV Technologies (DBVT) France $0.516B 0.00
Mesoblast (MESO) Australia $0.513B 0.00
UROGEN PHARMA (URGN) United States $0.509B 0.00
Magenta Therapeutics (MGTA) United States $0.504B 0.00
Axsome Therapeutics (AXSM) United States $0.503B 0.00
Arcus Biosciences (RCUS) United States $0.485B 0.00
AVROBIO (AVRO) United States $0.472B 0.00
Cytokineticsorporated (CYTK) United States $0.469B 0.00
Krystal Biotech (KRYS) United States $0.467B 0.00
Sorrento Therapeutics (SRNE) United States $0.462B 0.00
Anika Therapeutics (ANIK) United States $0.453B 17.12
Scholar Rock Holding (SRRK) United States $0.448B 0.00
KALEIDO BIOSCI (KLDO) $0.447B 0.00
PDL BioPharma (PDLI) United States $0.447B 9.97
ProQR Therapeutics (PRQR) Netherlands $0.441B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.440B 0.00
Replimune (REPL) United States $0.433B 0.00
Prothena (PRTA) Ireland $0.431B 0.00
CytomX Therapeutics (CTMX) United States $0.430B 0.00
Five Prime Therapeutics (FPRX) United States $0.427B 0.00
CYCLERION THERA (CYCN) United States $0.426B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.426B 0.00
Gritstone Oncology (GRTS) United States $0.425B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.424B 0.00
MediciNova (MNOV) United States $0.419B 0.00
Dynavax Technologies (DVAX) United States $0.407B 0.00
Adverum Biotechnologies (ADVM) United States $0.406B 0.00
Senesco Technologies (ELOX) United States $0.405B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.402B 0.00
STEALTH BIOTHER (MITO) United States $0.388B 0.00
Abeona Therapeutics (ABEO) United States $0.384B 0.00
Merus (MRUS) Netherlands $0.383B 0.00
Inovio Pharmaceuticals (INO) United States $0.371B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Albireo Pharma (ALBO) United States $0.369B 0.00
Kezar Life Sciences (KZR) United States $0.364B 0.00
Geron (GERN) United States $0.358B 0.00
UNITY Biotechnology (UBX) $0.352B 0.00
Kindred Biosciences (KIN) United States $0.344B 0.00
Agenus (AGEN) United States $0.341B 0.00
PHASEBIO PHARMA (PHAS) United States $0.340B 0.00
BeyondSpring (BYSI) United States $0.339B 0.00
XBiotech (XBIT) United States $0.329B 0.00
BioDelivery Sciences (BDSI) United States $0.328B 0.00
AC Immune SA (ACIU) Switzerland $0.322B 0.00
Solid Biosciences (SLDB) United States $0.319B 0.00
Constellation Pharmaceuticals (CNST) United States $0.318B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.315B 0.00
Cellular Biomedicine (CBMG) United States $0.307B 0.00
MannKind (MNKD) United States $0.299B 0.00
Kadmon Holdings (KDMN) United States $0.288B 0.00
Seres Therapeutics (MCRB) United States $0.284B 0.00
LogicBio Therapeutics (LOGC) United States $0.275B 0.00
Aduro Biotech (ADRO) United States $0.268B 0.00
Evelo Biosciences (EVLO) United States $0.266B 0.00
Kodiak Sciences (KOD) United States $0.264B 0.00
Kala Pharmaceuticals (KALA) United States $0.254B 0.00
Kamada (KMDA) Israel $0.251B 11.33
Enochian BioSciences (ENOB) United States $0.251B 0.00
Urovant Sciences (UROV) United States $0.250B 0.00
Novavax (NVAX) United States $0.248B 0.00
Cerecor (CERC) United States $0.245B 0.00
Strongbridge Biopharma (SBBP) United States $0.244B 0.00
Avid Bioservices (CDMO) United States $0.242B 0.00
Protagonist Therapeutics (PTGX) United States $0.240B 0.00
Syros Pharmaceuticals (SYRS) United States $0.233B 0.00
ResTORbio (TORC) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.227B 0.00
Celyad SA (CYAD) Belgium $0.222B 0.00
ChromaDex (CDXC) United States $0.221B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.219B 0.00
Palatin Technologies (PTN) United States $0.217B 107.00
OSMOTICA PHARM (OSMT) United States $0.216B 0.00
Celcuity (CELC) United States $0.214B 0.00
OvaScience (MLND) United States $0.214B 0.00
ADMA Biologics Inc (ADMA) United States $0.212B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.211B 0.00
Spero Therapeutics (SPRO) United States $0.211B 0.00
Gamida Cell (GMDA) Israel $0.211B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.211B 0.00
Intec Pharma (NTEC) Israel $0.210B 0.00
Athersys (ATHX) United States $0.210B 0.00
CorMedix Inc (CRMD) United States $0.209B 0.00
Cel-Sci (CVM) United States $0.203B 0.00
Axovant Sciences (AXGT) United Kingdom $0.201B 0.00
TOCAGEN INC (TOCA) United States $0.201B 0.00
Synlogic (SYBX) United States $0.200B 0.00
Mersana Therapeutics (MRSN) United States $0.200B 0.00
Arsanis (XFOR) United States $0.195B 0.00
VBI Vaccines (VBIV) United States $0.193B 0.00
Pfenex (PFNX) United States $0.182B 0.00
BioTime (BTX) United States $0.179B 0.00
Mustang Bio (MBIO) United States $0.178B 0.00
Arbutus Biopharma (ABUS) Canada $0.177B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.176B 0.00
Compugen (CGEN) Israel $0.176B 0.00
Enzo Biochem (ENZ) United States $0.171B 0.00
Cue Biopharma (CUE) United States $0.170B 0.00
Menlo Therapeutics (MNLO) United States $0.166B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.164B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.159B 0.00
Verastem (VSTM) United States $0.158B 0.00
BioXcel Therapeutics (BTAI) United States $0.155B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.152B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.147B 0.00
Chiasma (CHMA) United States $0.147B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.144B 0.00
Trevena (TRVN) United States $0.138B 0.00
Eton Pharmaceuticals (ETON) United States $0.134B 0.00
Anavex Life Sciences (AVXL) United States $0.132B 0.00
Liquidia Technologies (LQDA) United States $0.132B 0.00
Checkpoint Therapeutics (CKPT) United States $0.132B 0.00
Allena Pharmaceuticals (ALNA) United States $0.132B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.130B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.127B 0.00
VolitionRX (VNRX) Singapore $0.127B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.123B 0.00
Aptinyx (APTX) United States $0.123B 0.00
Organovo Holdings (ONVO) United States $0.121B 0.00
Neothetics (EVFM) United States $0.119B 0.00
Provention Bio (PRVB) United States $0.117B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.112B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.110B 0.00
XOMA (XOMA) United States $0.108B 0.00
Unum Therapeutics (UMRX) United States $0.108B 0.00
Fortress Biotech (FBIO) United States $0.107B 0.00
INMUNE BIO INC (INMB) United States $0.105B 0.00
Catalyst Biosciences (CBIO) United States $0.104B 0.00
Moleculin Biotech (MBRX) United States $0.102B 0.00
Selecta Biosciences (SELB) United States $0.097B 0.00
Equillium (EQ) United States $0.096B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.095B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Cohbar (CWBR) United States $0.095B 0.00
NantKwest (NK) United States $0.087B 0.00
Signal Genetics (MGEN) United States $0.084B 0.00
Cocrystal Pharma (COCP) United States $0.083B 87.33
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.083B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.083B 0.00
Applied Genetic Technologies (AGTC) United States $0.081B 0.00
Alcobra (ARCT) United States $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.080B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.079B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.078B 0.00
Eyenovia (EYEN) United States $0.077B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.077B 0.00
Aptose Biosciences (APTO) Canada $0.077B 0.00
Orgenesis (ORGS) United States $0.075B 0.00
ARAVIVE, INC (ARAV) United States $0.071B 0.00
OVID THERAPEUTC (OVID) United States $0.070B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
AEterna Zentaris (AEZS) United States $0.065B 15.88
Alimera Sciences (ALIM) United States $0.065B 0.00
Cidara Therapeutics (CDTX) United States $0.065B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.064B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
Zosano Pharma (ZSAN) United States $0.062B 0.00
Protalix BioTherapeutics (PLX) Israel $0.062B 0.00
Pluristem Therapeutics (PSTI) Israel $0.061B 0.00
VTv Therapeutics (VTVT) United States $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Ophthotech (ISEE) United States $0.059B 0.00
Curis (CRIS) United States $0.058B 0.00
Apricus Biosciences (SEEL) United States $0.058B 0.00
ScPharmaceuticals (SCPH) United States $0.056B 0.00
Evogene (EVGN) Israel $0.056B 0.00
Prima BioMed (IMMP) Australia $0.052B 0.00
HOTH THERAPEUTC (HOTH) United States $0.052B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.051B 0.00
AquaBounty Technologies (AQB) United States $0.050B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.050B 0.00
Entera Bio (ENTX) Israel $0.049B 0.00
AZURRX BIOPHARM (AZRX) United States $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Celsion (CLSN) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Celldex Therapeutics (CLDX) United States $0.045B 0.00
Bellerophon Therapeutics (BLPH) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
ANCHIANO THERAP (ANCN) Israel $0.043B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.041B 0.00
DiaMedica Therapeutics (DMAC) United States $0.041B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.040B 0.00
VIVUS (VVUS) United States $0.037B 0.00
OncoSec Medical (ONCS) United States $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.036B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.034B 0.00
Aptevo Therapeutics (APVO) United States $0.034B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Motif Bio Plc (MTFB) United States $0.032B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Sophiris Bio (SPHS) United States $0.029B 0.00
Adial Pharmaceuticals (ADIL) United States $0.027B 0.00
GTx (GTXI) United States $0.027B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
Vical (VICL) United States $0.025B 0.00
Aileron Therapeutics (ALRN) United States $0.025B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Oragenics (OGEN) United States $0.022B 0.00
Galena Biopharma (SLS) United States $0.022B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
TRACON Pharmaceuticals (TCON) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
Advaxis (ADXS) United States $0.019B 0.00
IMMURON LTD (IMRN) Australia $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.019B 0.00
CytRx (CYTR) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.019B 0.00
Histogenics (HSGX) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
Vital Therapies (IMUX) United States $0.015B 0.00
BioPharmX (BPMX) United States $0.015B 0.00
Alliqua BioMedical (ALQA) United States $0.015B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Dare Bioscience (DARE) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.89
Soligenix (SNGX) United States $0.012B 0.00
Neuralstem (CUR) United States $0.011B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.010B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Pulmatrix (PULM) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.009B 0.00
Edge Therapeutics (PDSB) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00